Patent details
EP3579837 Title: AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITIS
Basic Information
- Publication number:
- EP3579837
- PCT Application Number:
- US2018017810
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187510425
- PCT Publication Number:
- WO2018148653
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITIS
- French Title of Invention:
- AXITINIB, NINTEDANIB OU LENVATINIB POUR LE TRAITEMENT DE LA ROSACÉE ET DE LA DERMATITE ATOPIQUE
- German Title of Invention:
- AXITINIB, NINTEDANIB ODER LENVATINIB ZUR BEHANDLUNG VON ROSACEA UND ATOPISCHE DERMATITIS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 07/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 12/06/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 12/06/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 12/02/2018
- Grant date:
- 07/06/2023
- EP Publication Date:
- 18/12/2019
- PCT Publication Date:
- 16/08/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/02/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- AiViva Biopharma, Inc.
- Address:
- 848 North Rainbow Boulevard, Suite 2654, Las Vegas, NV 89107, United States (US)
Inventor
1
- Name:
- DEVRIES, Gerald, Woodrow
- Address:
- United States (US)
2
- Name:
- TANG-LIU, Diane
- Address:
- United States (US)
Priority
- Priority Number:
- 201762457929 P
- Priority Date:
- 12/02/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4439; A61K 31/496; A61K 31/47; A61P 17/00; A61P 17/02; A61P 17/06; A61K 9/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202328
- Publication date:
- 12/07/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202328
- Publication date:
- 12/07/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|